Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Andruska

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2022
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy AloneNeal Andruska, Benjamin W Fischer-Valuck, Ruben Carmona, et al.
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Brachytherapy|May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapyNeal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
JAMA Dermatology|March 24, 2021
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell CarcinomaNeal Andruska, Benjamin W Fischer-Valuck, Lily Mahapatra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2020
Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastasesNeal Andruska, William R Kennedy, Liberty Bonestroo, et al.
Blood Advances|April 24, 2023
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiationAlexander B Kim, Ssu-Yu Chou, Solomon Kang, et al.
Practical Radiation Oncology|October 25, 2021
Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate CancerRandall J Brenneman, S Murty Goddu, Neal Andruska, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2020
Regional lymph node irradiation in locally advanced Merkel cell carcinoma reduces regional and distant relapse and improves disease-specific survivalNeal Andruska, Lily Mahapatra, Randall J Brenneman, et al.
Clinical and Translational Radiation Oncology|November 29, 2023
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancerMichael Waters, Alex Price, Eric Laugeman, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2022
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy AloneNeal Andruska, Benjamin W Fischer-Valuck, Ruben Carmona, et al.
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Brachytherapy|May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapyNeal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
JAMA Dermatology|March 24, 2021
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell CarcinomaNeal Andruska, Benjamin W Fischer-Valuck, Lily Mahapatra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2020
Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastasesNeal Andruska, William R Kennedy, Liberty Bonestroo, et al.
Blood Advances|April 24, 2023
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiationAlexander B Kim, Ssu-Yu Chou, Solomon Kang, et al.
Practical Radiation Oncology|October 25, 2021
Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate CancerRandall J Brenneman, S Murty Goddu, Neal Andruska, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2020
Regional lymph node irradiation in locally advanced Merkel cell carcinoma reduces regional and distant relapse and improves disease-specific survivalNeal Andruska, Lily Mahapatra, Randall J Brenneman, et al.
Clinical and Translational Radiation Oncology|November 29, 2023
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancerMichael Waters, Alex Price, Eric Laugeman, et al.
Pageof 4